A randomised, prospective study, assessing changes in cerebral function in treatment naive HIV-1 infected subjects commencing either boosted atazanavir with Truvada or boosted darunavir with maraviroc
Design and Objective
An open-label, prospective, randomised clinical trial to investigate differences in changes in neurocognitive function in HIV infected subjects commencing two different antiretroviral regimens for the first time.
Key inclusion criteria
HIV-1 infected males or females, aged 18 years or above, with no previous antiretroviral treatment since HIV diagnosis.